Alphabet
Latest statistics and disclosures from Alphabet's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PATH, CRWD, VERV, GTLB, PRME, and represent 53.20% of Alphabet's stock portfolio.
- Added to shares of these 3 stocks: Arm Holdings (+$105M), Dianthus Therapeutics, Neumora Therapeutics.
- Started 3 new stock positions in Neumora Therapeutics, Dianthus Therapeutics, Arm Holdings.
- Reduced shares in these 7 stocks: OSCR (-$53M), DXCM (-$52M), LYFT (-$36M), Decibel Therapeutics (-$6.3M), HOOD (-$6.1M), Magenta Therapeutics, OPRT.
- Sold out of its positions in Decibel Therapeutics, LYFT, Magenta Therapeutics, OPRT, HOOD.
- Alphabet was a net seller of stock by $-46M.
- Alphabet has $1.6B in assets under management (AUM), dropping by -16.34%.
- Central Index Key (CIK): 0001652044
Tip: Access up to 7 years of quarterly data
Positions held by Alphabet consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Alphabet
Alphabet holds 45 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Uipath Cl A (PATH) | 15.5 | $241M | 14M | 17.11 |
|
|
| Crowdstrike Hldgs Cl A (CRWD) | 13.8 | $215M | 1.3M | 167.38 |
|
|
| Verve Therapeutics (VERV) | 9.0 | $140M | 11M | 13.26 |
|
|
| Gitlab Class A Com (GTLB) | 7.7 | $120M | 2.6M | 45.22 |
|
|
| Prime Medicine (PRME) | 7.3 | $113M | 12M | 9.54 |
|
|
| Eqrx (EQRX) | 6.8 | $106M | 48M | 2.22 |
|
|
| Arm Holdings Sponsored Adr | 6.7 | $105M | NEW | 2.0M | 53.52 |
|
| Planet Labs Pbc Com Cl A (PL) | 5.3 | $83M | 32M | 2.60 |
|
|
| Snowflake Cl A (SNOW) | 5.3 | $82M | 536k | 152.77 |
|
|
| Oscar Health Cl A (OSCR) | 5.2 | $81M | -39% | 15M | 5.57 |
|
| Freshworks Class A Com (FRSH) | 5.2 | $80M | 4.0M | 19.92 |
|
|
| Dex (DXCM) | 3.9 | $61M | -46% | 655k | 93.30 |
|
| Desktop Metal Com Cl A (DM) | 1.0 | $16M | 11M | 1.46 |
|
|
| Relay Therapeutics (RLAY) | 0.8 | $13M | 1.6M | 8.41 |
|
|
| Sana Biotechnology (SANA) | 0.7 | $11M | 2.8M | 3.87 |
|
|
| Adagio Therapeutics (IVVD) | 0.6 | $9.7M | 5.7M | 1.70 |
|
|
| Rapt Therapeutics (RAPT) | 0.6 | $9.0M | 540k | 16.62 |
|
|
| Lyell Immunopharma (LYEL) | 0.6 | $8.6M | 5.9M | 1.47 |
|
|
| Beam Therapeutics (BEAM) | 0.5 | $7.7M | 322k | 24.05 |
|
|
| Illumina (ILMN) | 0.5 | $7.3M | 54k | 137.28 |
|
|
| Monte Rosa Therapeutics (GLUE) | 0.5 | $7.0M | 1.5M | 4.79 |
|
|
| Benson Hill Common Stock (BHIL) | 0.3 | $5.1M | 15M | 0.33 |
|
|
| Vaccitech Ads (VACC) | 0.3 | $4.7M | 1.5M | 3.09 |
|
|
| Vera Therapeutics Cl A (VERA) | 0.3 | $4.1M | 302k | 13.71 |
|
|
| Dianthus Therapeutics | 0.2 | $2.9M | NEW | 209k | 13.67 |
|
| Neumora Therapeutics | 0.2 | $2.8M | NEW | 200k | 14.11 |
|
| Tscan Therapeutics (TCRX) | 0.2 | $2.8M | 1.1M | 2.56 |
|
|
| Foghorn Therapeutics (FHTX) | 0.2 | $2.5M | 501k | 5.00 |
|
|
| Tenaya Therapeutics (TNYA) | 0.1 | $2.3M | 916k | 2.55 |
|
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.1 | $2.0M | 641k | 3.16 |
|
|
| Kronos Bio (KRON) | 0.1 | $1.9M | 1.4M | 1.30 |
|
|
| Hyperfine Com Cl A (HYPR) | 0.1 | $1.8M | 899k | 2.05 |
|
|
| Autolus Therapeutics Spon Adr (AUTL) | 0.1 | $1.6M | 698k | 2.33 |
|
|
| EXACT Sciences Corporation (EXAS) | 0.1 | $1.6M | 23k | 68.22 |
|
|
| Science 37 Holdings (SNCE) | 0.1 | $1.3M | 3.2M | 0.40 |
|
|
| Alector (ALEC) | 0.1 | $1.1M | 176k | 6.48 |
|
|
| Spero Therapeutics (SPRO) | 0.1 | $1.1M | 890k | 1.21 |
|
|
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.1 | $973k | 449k | 2.17 |
|
|
| Cortexyme (QNCX) | 0.0 | $212k | 189k | 1.12 |
|
|
| Evelo Biosciences Com New (EVLO) | 0.0 | $208k | 53k | 3.92 |
|
|
| Invitae (NVTA) | 0.0 | $144k | 236k | 0.61 |
|
|
| Mondee Holdings Class A Com (MOND) | 0.0 | $66k | 18k | 3.57 |
|
|
| Fulcrum Therapeutics (FULC) | 0.0 | $63k | 14k | 4.44 |
|
|
| Repligen Corporation (RGEN) | 0.0 | $61k | 383.00 | 159.01 |
|
|
| Cue Health (HLTH) | 0.0 | $12k | 27k | 0.44 |
|
Past Filings by Alphabet
SEC 13F filings are viewable for Alphabet going back to 2022
- Alphabet 2023 Q3 filed Nov. 13, 2023
- Alphabet 2023 Q2 filed Aug. 4, 2023
- Alphabet 2023 Q1 filed May 11, 2023
- Alphabet 2022 Q4 filed Feb. 14, 2023
- Alphabet 2022 Q3 filed Nov. 15, 2022
- Alphabet 2013 Q4 filed Nov. 15, 2022
- Alphabet 2014 Q1 filed Nov. 15, 2022
- Alphabet 2014 Q2 filed Nov. 15, 2022
- Alphabet 2014 Q3 filed Nov. 15, 2022
- Alphabet 2014 Q4 filed Nov. 15, 2022
- Alphabet 2015 Q1 filed Nov. 15, 2022
- Alphabet 2015 Q2 filed Nov. 15, 2022
- Alphabet 2015 Q3 filed Nov. 15, 2022
- Alphabet 2015 Q4 filed Nov. 15, 2022
- Alphabet 2016 Q1 filed Nov. 15, 2022
- Alphabet 2016 Q2 filed Nov. 15, 2022